Memorial Sloan Kettering Cancer Center | January 13, 2026
The Future of Melanoma Treatment in 2026
Join Us for a Highly Anticipated Melanoma Discussion
AIM at Melanoma is proud to host this virtual event on Tuesday, January 13th, from 5:30 – 7:00 PM ET, featuring top melanoma specialists from Memorial Sloan Kettering Cancer Center. This discussion is designed to provide patients, caregivers, and healthcare professionals with the latest advancements in melanoma treatment and research.
Discussion Highlights:
- Latest Advances in Frontline Melanoma Treatment: Who should receive which immunotherapy?
- Options for PD-1 Refractory Melanoma: Best strategies when initial anti-PD-1 treatment fails.
- Tumor-Infiltrating Lymphocyte (TIL) & Novel Cellular Therapies: Current status and next steps following Lifileucel’s approval.
- Less Common Melanoma Subtypes: Emerging treatment strategies for Uveal, Mucosal, and Acral melanoma.
Co-Hosts:
- Dr. Michael Postow, Memorial Sloan Kettering Cancer Center
- Dr. Alexander Shoushtari, Memorial Sloan Kettering Cancer Center
This is a unique opportunity to hear directly from leading experts in the field and stay informed about the evolving landscape of melanoma care—all from the comfort of your home.